389 related articles for article (PubMed ID: 16859903)
21. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
22. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
Mitchell JA; Warner TD
Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347
[TBL] [Abstract][Full Text] [Related]
23. New insights into COX-2 biology and inhibition.
Patrignani P; Tacconelli S; Sciulli MG; Capone ML
Brain Res Brain Res Rev; 2005 Apr; 48(2):352-9. PubMed ID: 15850674
[TBL] [Abstract][Full Text] [Related]
24. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
Wallace JL; Vong L
Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
[TBL] [Abstract][Full Text] [Related]
25. Aspirin and NSAID sensitivity.
Stevenson DD
Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
[TBL] [Abstract][Full Text] [Related]
26. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
Lees P; Landoni MF; Giraudel J; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
[TBL] [Abstract][Full Text] [Related]
28. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
Tomisato W; Tsutsumi S; Hoshino T; Hwang HJ; Mio M; Tsuchiya T; Mizushima T
Biochem Pharmacol; 2004 Feb; 67(3):575-85. PubMed ID: 15037209
[TBL] [Abstract][Full Text] [Related]
29. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system.
Fosslien E
Ann Clin Lab Sci; 1998; 28(2):67-81. PubMed ID: 9558445
[TBL] [Abstract][Full Text] [Related]
30. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
[TBL] [Abstract][Full Text] [Related]
31. The effects of cyclo-oxygenase inhibitors on bile-injured and normal equine colon.
Campbell NB; Jones SL; Blikslager AT
Equine Vet J; 2002 Jul; 34(5):493-8. PubMed ID: 12358053
[TBL] [Abstract][Full Text] [Related]
32. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
34. Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives.
Bruno A; Tacconelli S; Patrignani P
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):56-63. PubMed ID: 23953622
[TBL] [Abstract][Full Text] [Related]
35. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process.
Vuolteenaho K; Moilanen T; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):10-4. PubMed ID: 17973900
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory agents and renal function.
Brater DC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
[TBL] [Abstract][Full Text] [Related]
37. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs).
Wallace JL
Am J Med; 1999 Dec; 107(6A):11S-16S; discussion 16S-17S. PubMed ID: 10628589
[TBL] [Abstract][Full Text] [Related]
38. Tissue selective inhibition of prostaglandin biosynthesis by etodolac.
Dvornik DM
J Rheumatol Suppl; 1997 Feb; 47():40-7. PubMed ID: 9035019
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic of cyclooxygenase inhibitors in humans.
Capone ML; Tacconelli S; Di Francesco L; Sacchetti A; Sciulli MG; Patrignani P
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):85-94. PubMed ID: 17164136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
